Recent Headlines
Within Pharmaceuticals
Evolution Analytics Named Among Top 20 AI Solution Providers for 2024 by Enterprise Viewpoint
Evolution Analytics, a premier data and analytics consulting firm for mid-market organizations, has been recognized in Enterprise Viewpoint's Top 20 AI Solution Providers for 2024. This recognition highlights Evolution Analytics' strategic approach to leveraging AI through its EAAdvantage™ Analytics Framework, its alignment of technology adoption with business goals, and its growing influence across various sectors. - March 06, 2024 - Evolution Analytics
ALS TDI Launches ALS Trial Navigator: A Revolutionary Platform to Simplify Access to Clinical Trials
The ALS Therapy Development Insitute (ALS TDI) has announced the beta launch of the ALS Trial Navigator. This innovative set of tools is designed to guide people with ALS and caregivers through the process of finding and understanding ALS clinical trials – with the ultimate goal of personalizing the search process and helping users make informed decisions about participation in trials. - February 29, 2024 - ALS Therapy Development Institute
IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024
IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation... - February 28, 2024 - iView Therapeutics Inc.
Creative Biolabs Supplies Recombinant Antibodies for Pharmaceutical Breakthroughs
Creative Biolabs reaffirmed its dedication to supplying high-quality antibody reagents in 2024. - February 28, 2024 - Creative Biolabs
Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies
Cayman Chemical introduces the latest addition to the company’s portfolio of lipid nanoparticle (LNP) research tools for academic, pharma, and biotech researchers worldwide. The LipidLaunch™ product line helps researchers pursue LNPs for the delivery of nucleic acid therapies in untold health applications, ranging from vaccine development to cancer and cell or gene therapies. - February 22, 2024 - Cayman Chemical Company
New LGBTQ+ Screenplay Wins Platinum in Film Festival
Long Island writer debuts emotional story based on true events shining much needed light on opioid crisis in queer community. "You Are What You Love," a sapphic drama about a young woman struggling with recovery from her opioid addiction while navigating love and loss, recently won Platinum in the LGBTQ Unbordered International Film Festival. The screenplay, based on true events, gives a realistic portrayal of the unique obstacles the LGBTQ+ community faces. - February 15, 2024 - Worthy
Gotham Biotech’s Histoplasma Urinary Antigen EIA Kit Now Available for Purchase as Histoplasma Spreads in the U.S.
Histoplasmosis is a systemic disease caused by the thermally dimorphic fungus Histoplasma capsulatum. H. capsulatum is distributed worldwide and endemic to the Ohio and Mississippi River Valleys, where the CDC estimates 60% to 90% of people who live in the region have been exposed to the fungus at some point during their life, and to certain regions of Central and South America. Medicare records from 2007 to 2016 have found cases of histoplasmosis have now spread to 47 states and Washington, DC. - February 15, 2024 - Gotham Biotech
GENINVO, a Leading Provider of Life Science Product and Business Solutions Announced the Offering of Its On-Demand Service/Tool: ApoGI™
ApoGI™ is an integrated, one stop automation platform that leverages Artificial Intelligence and Machine Learning algorithms to focus on standards and metadata driven generation of artifacts. The Primary objective of this platform is to help SMEs (Subject matter experts) focus on curating... - February 15, 2024 - GenInvo, Inc.
NAD3® Supplement Study: Memphis Health Sciences College Discovers Key to Cellular Rejuvenation
In a groundbreaking development, the College of Health Sciences at the University of Memphis, spearheaded by leading researchers Janine Hellenbrand, Richard J. Bloomer, and Marie Van der Merwe, has revealed the remarkable effects of NAD3® supplementation on adult stem cell circulation in... - February 14, 2024 - High Performance Nutrition
Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report
Sponsor Outsourcing Dollars May Shift to Clinical Site Networks, Transforming the CRO Relationship - February 13, 2024 - Life Science Strategy Group, LLC
New Audio Feature for the Popular GCP Training
Pharma Lessons has added voice over functionality to their popular International Good Clinical Practice training. The audio is beautifully matched with the content of the course and is created by a native US speaker who is also a professional e-learning narrator. The voiceover has been recorded... - February 11, 2024 - Pharma Lessons
Microvascular Therapeutics Welcomes Thom Tulip as Chief Business Officer
Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing the next generation of microbubbles unlocking the therapeutic potential of ultrasound, proudly announces the appointment of Dr Thom Tulip as their new Chief Business Officer. In this pivotal role, Dr Tulip will lead capital raises to propel MVT's cutting-edge technologies into the market. - February 10, 2024 - Microvascular Therapeutics, Inc.
expEDIum Announces Successful Partnership with Medical Billing Service & Long-Term Care Medical Group, Inc.
Expanding its footprint in the healthcare industry, expEDIum is excited to announce the successful collaboration with Long-Term Care Medical Group, Inc. The partnership, initiated in October 2022, has flourished into a dynamic relationship, with Ms. Balwinder Bains, owner of the Medical Billing... - February 08, 2024 - expEDIum
Flow Circuits and Rapid Fluidics Ltd. Announce Partnership to Drive Microfluidic Innovation
Flow Circuits design platform and Rapid Fluidics 3D Print capabilities perfectly complement each other for rapid fluidic system development. Combined they empower researchers in diverse markets such as Pharmaceutical & Life Sciences Research, Point of Care Testing and Clinical Diagnostics, and Environment and Industrial Analytics. - February 05, 2024 - Rapid Fluidics Ltd
Accelerating Drug Discovery: Life Science and IT Leaders Explore the Power of Artificial Intelligence April 15-17 in Boston
AI to Take Center Stage at Bio-IT World Conference & Expo, the Hub for Pharmaceutical, Biotech and IT Collaboration - February 04, 2024 - Cambridge Healthtech Institute
Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy
Creative Diagnostics has announced its extensive portfolio of AAV Reagent Solutions to support researchers. - February 04, 2024 - Creative Diagnostics
Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens
Creative Diagnostics is pleased to announce the launch of its Serum Plate Agglutination Test. - February 04, 2024 - Creative Diagnostics
Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety
Creative Diagnostics has announced the launch of Aflatoxin Test Reagents to detect harmful mycotoxins in various food products. - February 04, 2024 - Creative Diagnostics
Patient Experience and Satisfaction with Electronic Consent, Onboarding, and Diaries in Clinical Trials Report
New Market Research Shows Different Patient Preferences for Electronic Diaries - January 31, 2024 - Life Science Strategy Group, LLC
New Sustainable Lyophilization Technology Uses Supercritical CO2
The Thar group of companies have been using CO2 for extraction, purification, particle design and encapsulation for many years but recent developments point to a need for sustainable methods for drying APIs, intermediates, excipients and biologics at relatively low temperatures. 'Big Pharma' has depended on Thar for SFC tools in drug discovery but lyophilization will likely be used in manufacturing too. - January 28, 2024 - Thar Process, LLC
George W. Denninghoff Appointed EVP, Americas at Simms & Associates
Simms & Associates proudly welcomes George W. Denninghoff as Executive Vice President, Americas. With 25+ years of success in driving revenues and fostering customer satisfaction, George aligns his expertise with the company's North American growth goals. CEO Amanda Simms sees his appointment as pivotal in advancing Simms & Associates' global leadership in workforce management. - January 26, 2024 - Simms & Associates
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics has announced the launch of its new Robenidine Test Reagents for the detection of robenidine residues. - January 26, 2024 - Creative Diagnostics
Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness
Creative Diagnostics has announced new Minimum Doubling Time (MDT) services to measure the effectiveness of antibacterial compounds. - January 26, 2024 - Creative Diagnostics
Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research
Creative Diagnostics has announced P53 and TP53 antibodies and solutions to support cancer research. - January 26, 2024 - Creative Diagnostics
Huntington Study Group Announces 2024 Annual Meeting
The Huntington Study Group® (HSG), together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), is pleased to announce that its annual meeting for 2024 is slated to take place from November 6-9 at the... - January 22, 2024 - Huntington Study Group
The Aesthetic Institute Announces Comprehensive Clinical Trial Programs in Advanced Aesthetic Techniques
The Aesthetic Institute is a leading center for medical aesthetics and anti-aging medicine, founded by Dr. Adam Summers, who is ranked by Newsweek as one of the nation’s top plastic surgeons. The Institute has launched an expanded clinical trial program to test new technologies and protocols in various aesthetic treatments, such as chemical peels, laser hair removal, and laser skin resurfacing that is now open to the general public. - January 22, 2024 - The Aesthetic Institute
Johari Digital Healthcare Limited Hosts Successful Webinar on Design for Manufacturing (DFM) for Medical Devices
Johari Digital Healthcare hosted a successful webinar on "Building Cost-effective Medical Devices through Design for Manufacturing." The 60-minute event discussed challenges in balancing cost and product robustness, featuring real-world case studies. Speakers highlighted early DFM benefits, such as cost reduction and faster time-to-market. - January 22, 2024 - Johari Digital Healthcare Ltd.
Impact of the In Vitro Diagnostic Regulation on Clinical Trials in the EU and CRO Outsourcing Report
IVDR Delays Driving Trial Sponsors to Actively Seek Alternative Site and CRO Outsourcing Strategies - January 17, 2024 - Life Science Strategy Group, LLC
NuvOx Pharma Announces Issuance of a New Patent
NuvOx Pharma has been issued US Patent No. 11,857,627, entitled “Fractionated Radiotherapy and Chemotherapy with an Oxygen Therapeutic.” - January 14, 2024 - NuvOx Therapeutics
New Ultra-Thin, Compact Low-Height, Low-Frequency Vibration Isolation Platform Adapts to Space Constraints in Critical Micro- and Nano-Microscopy
At about 2-1/2 inches in height, while isolating vibrations as low as 1 hertz, the new completely-passive Negative-Stiffness tabletop vibration isolation platform – developed by Minus K Technology – provides the industry’s thinnest low-height, low-frequency isolator for Microscopy (SPM, SEM, AFM, etc.), Micro-Hardness and Nano-Indenter Testing, Laser/Optical Systems, Biology/Neuroscience Systems, Spacecraft Ground Testing, Analytical Balances, Audio Reproduction, Vacuum & Cleanroom applications. - January 10, 2024 - Minus K Technology Inc.
Zifo Named Fastest Growing Technology Company in Deloitte Technology Fast 50 India 2023
Zifo has bagged this award for the 11th consecutive time. - December 20, 2023 - Zifo
ALPCO Announces the Commercial Launch of Its FDA 510(K) Cleared Calprotectin Immunoturbidimetric Assay
American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) diagnostic solutions. In July... - December 19, 2023 - ALPCO
Johari Digital Healthcare Ltd. Clinches Prestigious "Pharmaceutical & Healthcare MSME of the Year" Award at ET MSME Awards 2023
Johari Digital Healthcare Ltd. has clinched the esteemed "Pharmaceutical & Healthcare MSME of the Year" award at the ET MSME Awards 2023 in New Delhi. Celebrating the resilience of India's MSME sector, the event recognized Johari Digital Healthcare Ltd. for its exceptional contributions to healthcare, particularly in manufacturing and research & development. - December 18, 2023 - Johari Digital Healthcare Ltd.
expEDIum Introduces Office EHR and InstaPay, Along with Strategic Rebranding
Expanding its healthcare technology offerings, iTech announces expEDIum Office EHR, a robust Electronic Health Records (EHR) solution, alongside the unveiling of expEDIum InstaPay (eIP) for patient online payment convenience. This move signifies iTech's commitment to delivering practical,... - December 17, 2023 - expEDIum
Empowering Data Privacy: GENINVO Offers Anonymization as a Service
GENINVO, a leading provider of life science product and business solutions announced the offering of its on-demand service Anonymization as a Service. GENINVO a trailblazer in data privacy solutions, is excited to introduce its ground-breaking offering, Anonymization as a Service. With data... - December 14, 2023 - GenInvo, Inc.
Hexa Global Ventures Unveils TalentEdgeAI: a Revolutionary Solution to Transform Talent Acquisition and Staffing
TalentEdgeAI is revolutionizing the HR tech landscape by offering a unified platform specifically designed for mid-sized employers and staffing firms. It is providing a seamless, AI-driven solution that intelligently analyzes labor market trends, pinpoints ideal candidates, and optimizes the interview process with the power of AI and machine learning. This doesn't streamline recruitment – it redefines it by accelerating the process, improving the experience, and increasing candidate quality. - December 13, 2023 - TalentEdgeAI
Huntington Study Group and Roche Collaborate on GENERATION HD2 Study
The Huntington Study Group together with its wholly-owned clinical research organization, HSG Clinical Research, Inc. (HSGCR), is pleased to announce a collaboration with Roche-Genentech to optimize our collective experiences in Huntington’s disease (HD) clinical research. Together we are... - December 13, 2023 - Huntington Study Group
Microvascular Therapeutics Selected as a Participant in the 2023 H7 BioCapital Accelerator Program
Microvascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has been selected to join the prestigious H7 Healthcare Accelerator 2023 Cohort, powered by H7 BioCapital. The program is renowned for providing a dynamic platform... - December 13, 2023 - Microvascular Therapeutics, Inc.
Creative Diagnostics Launches Macrophage Migration Inhibitory Factor Reagents for Research Applications
Creative Diagnostics has launched a portfolio of Macrophage Migration Inhibitory Factor (MIF) reagents for researchers. - December 13, 2023 - Creative Diagnostics
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing
Creative Diagnostics has announced the launch of its new Minimum Bactericidal Concentration (MBC) Assay for antibacterial testing. - December 13, 2023 - Creative Diagnostics
Creative Diagnostics Announces New Test Reagents for Dapsone
Creative Diagnostics has announced the launch of a range of new reagents for the analysis of Dapsone in food. - December 13, 2023 - Creative Diagnostics
Breakthrough Study by Microvascular Therapeutics Reveals Fibrin-Targeted Phase Shift Microbubbles as Promising Solution for Microvascular Obstruction
Microvascular Therapeutics, a trailblazing healthcare research and development company, announces a groundbreaking study on the treatment of Microvascular Obstruction (MVO) through sonoreperfusion. The study, led by Dr. John J. Pacella and his team at the Center for Ultrasound Molecular Imaging and... - December 13, 2023 - Microvascular Therapeutics, Inc.
Booth Unveiling Soon: Creative Biolabs and Ingenious Antibody Products at AET US 2023
Creative Biolabs highlights its participation in the upcoming Antibody Engineering and Therapeutics US 2023 conference, taking place from December 13–16, 2023. The event will be held in San Diego. - December 07, 2023 - Creative Biolabs
QuBind.com Makes Major Strides in T-Cell Immunotherapy with Revolutionary AI Innovation
In just 18 months, the young startup QuBind.com has achieved a remarkable breakthrough in T-cell immunotherapy, developing an advanced AI stack that is set to revolutionize personalized medicine. This significant milestone, reached with predominantly bootstrap funding, support from friends, family, and a strategic investment from a handful general partners in the PE sector, underscores the company's innovative spirit and scientific prowess. - December 05, 2023 - QuBind Technologies Corp
Announcing the Ales for ALS™ Roadtrip Across America
Over the coming months, Ales for ALS™ will be traveling across the country in an RV to connect with brewers and beer drinkers – all in support of ALS research. - December 04, 2023 - ALS Therapy Development Institute
cyberelements Launches an Attractive Program for MSPs
Since its launch at the beginning of the year, cyberelements has met great success in Europe, delivering business performance with cyber trust, with its “ready in 3 minutes” platform. cyberelements solve the c-level executives’ impossible equation of speed to compliance, shortage... - December 04, 2023 - cyberelements
Blockchain in Healthcare Predictions 2024
The leading peer reviewed specialty journal, Blockchain in Healthcare Today Platform Approaches Journal (BHTY), has published its annual Predictions article for 2024. Subject matter experts forecast near term expectations for the healthcare industry. - December 02, 2023 - Blockchain in Healthcare Today
Medical Device Manufacturers Who Want to Understand the Requirements of the Uk’s New MHRA MORE Platform for Submissions of Device Related Incidents
Quality First International encourages all medical device manufacturers who want to understand the requirements of the UK’s new MORE platform for submissions of device related incidents to participate in their new webinar. - December 01, 2023 - Quality First International
Herb Llama Launches Plant-Based, Adaptogenic Superfood Supplements: a Revolution in Modern Holistic Wellness
Herb Llama, an American wellness company, has launched a new range of adaptogenic, plant-based superfood supplements targeting health-conscious adults. The company, driven by the motto "vitamins as nature intended," ensures its plant-based products align with modern holistic wellness. - November 30, 2023 - Herb Llama
Clear Choice Dermatology Expands to Longview, WA, with New Dermatology and Wound Care Clinic
Clear Choice Dermatology expands with a new clinic in Longview, Washington, featuring dermatology services and a Wound Care & Vascular Medicine division. Clear Choice Dermatology aims to deliver top-tier healthcare services to Longview, reaffirming its commitment to comprehensive dermatological, wound care, and vascular medicine solutions. - November 30, 2023 - Clear Choice Dermatology